209 |
2024/03 (Mar) |
HIRA vs. DAXX: the two axes shaping the histone H3.3 landscape |
885 |
208 |
2024/03 (Mar) |
Pathological phenotypes of astrocytes in Alzheimer’s disease |
868 |
207 |
2024/03 (Mar) |
Exploring the potential of Toxoplasma gondii as a drug development and delivery system |
849 |
206 |
2024/03 (Mar) |
Distinct characteristics of the DNA damage response in mammalian oocytes |
836 |
205 |
2024/03 (Mar) |
Current understanding of the Alzheimer’s disease-associated microbiome and therapeutic strategies |
829 |
204 |
2024/03 (Mar) |
Acid sphingomyelinase as a pathological and therapeutic target in neurological disorders: focus on Alzheimer's disease |
768 |
203 |
2024/03 (Mar) |
Effects of fine particulate matter on bone marrow-conserved hematopoietic and mesenchymal stem cells: a systematic review |
833 |
202 |
2024/03 (Mar) |
Deciphering the molecular mechanisms of stem cell dynamics in hair follicle regeneration. |
851 |
201 |
2024/03 (Mar) |
4-1BB immunotherapy: advances and hurdles |
811 |
200 |
2024/03 (Mar) |
Microbial underdogs: exploring the significance of low-abundance commensals in host-microbe interactions |
796 |